New York81°

New York81°

July 4, 2020 CONTACT

Julie Aitcheson, Author at Hemp Market Report

Julie AitchesonJulie AitchesonJune 29, 2020


Prior to giving Wana Brands’ Wana Wellness Quick line a test drive, I had the opportunity to speak with Mike Hennessy, Wana Brands Director of Innovation, and Dr. Christopher Shade, CEO of Quicksilver Scientific on their collaboration to bring this cost-effective, maximally potent, and botanically-enhanced CBD tincture to market. Wana Brands’ Quick line of CBD tinctures uses advanced nanoemulsion technology that dramatically enhances absorption and bioavailability, and botanical extracts selected to act as “assistants” to specific cannabinoids in an entourage effect, to offer what Hennessy and Shade believe put their CBD tinctures at the front of the pack.

Using botanical extracts to enhance the therapeutic effects of CBD and other cannabinoids is not an innovation exclusive to Wana Brands or Quicksilver, but Dr. Shade is eager to point out that Quicksilver Scientific is the market leader in developing enhanced nanoemulsified products whose efficacy is backed by data and in-house measuring devices that few if any other companies possess.  “Some companies use “nano” as a buzzword but are not getting the particles small enough,” Mike Hennessy confirms. “One hundred nanometers is the established definition, but almost no one has the ability to measure that apart from us.”

Advanced Nanoemulsion

According to Dr. Shade, Quicksilver’s mastery of advanced nanoemulsion effectively accomplishes what so many other products merely pay lip service to, in the form of a tincture whose therapeutic effect can be felt within mere minutes of ingestion with at least six times the bioavailability of other CBD formulas. “And by including botanical extracts with similar effects to the strains used,” he adds, “you increase the number of receptor sites in the body that can receive the effect.”

To better grasp the significance of “nanoemulsions” and “receptor sites”, I tried out the Wana Wellness “Relax” formula, which in addition to delivering 13mg of hemp and 10mg of CBD per bottle comes enhanced with 5-HTP, GABA, L-Theanine, skullcap, and rose essential oil for what Dr. Shade characterizes as a “purifying and calming effect.” 

The formula comes in a pump bottle, with each dose requiring four pumps. I found the delivery method a bit messy until I worked out that I needed to put the nozzle nearly in my mouth and depress the pump quickly and firmly. The taste was sweet verging on cloying, with a slight bitter aftertaste common to CBD tinctures. Though I’ve sampled dozens of formulations, this was my first experience with “advanced nanoemulsion technology”, and the difference was noticeable. I felt a pleasant lassitude within five minutes, with attendant muscle relaxation and a quieting of mental chatter. As I continued to use the product, the effects persisted, so much so that I began keeping it by my bed rather than on my kitchen counter, so quickly did the relaxation kick in.  

Quicksilver Scientifics and Wana Brands intend to continue developing out the union between cannabinoids and their botanical counterparts, which will include developing THC products for dispensaries. As far as this satisfied customer is concerned, that is welcome news indeed.

Julie AitchesonJulie AitchesonJune 18, 2020


CBD brand Elixinol’s claim of making “kind of amazing CBD products that work” is enticing without being truly hyperbolic—a claim that I recently investigated myself by sampling their “Stress Less” and “Body Comfort” capsules, as well as their “Daily Balance” tincture. 

Before trying the products from this Colorado-based company, I visited Elixinol’s website to learn a little bit more about them. In addition to an “Education” tab which led me to a helpful breakdown of FAQ’s with appealing graphics, the website specifies that their products are made from hemp grown within the USA, and that all partners are carefully vetted to meet Elixinol’s high standards of quality. Nothing groundbreaking there, but what is new is the growing trend towards pairing cannabinoids with botanical extracts in order to enhance targeted formulas. 

Elixinol’s “Stress Less” capsules contain 300mg of Ashwagandha, a root popular in Ayurveda for helping the body adapt and remain resilient under stress, and their “Body Comfort” capsules contain 275mg of Boswellia (the resin also called “frankincense”), which is a known anti-inflammatory. As someone with a fair amount of herbal training, I was excited to try these botanically-enhanced capsules and see if they produced noticeably different results from the 100% CBD products I’ve sampled. 

With the “Stress Less” formula, I did notice an enhanced capacity to maintain a sense of calm focus, and an ability to simply sit and enjoy a quiet moment rather than racing off to the next task. Falling asleep at night was also slightly less effortful. I exercise vigorously five or six times a week which can often lead to stiffness and soreness, especially after sedentary hours at my writing desk, so I was hopeful about the effects of the “Body Comfort” formula. While I can’t say that I noticed anything significantly different from the calm relaxation of the “Stress Less” formula (my neck pain persisted, as did the aches and pains when I hit the HIIT a little too hard), the overall sense of well-being was still most welcome.  

The “Daily Balance” tincture had a pleasant minty flavor and the light nuttiness of MCT oil that I prefer in my CBD extracts. At half a dropper (8mg) per recommended dose, I was able to take this one twice daily without fear that I would feel too sluggish or chilled out to tackle my to-do list. The effects were subtle beyond my ability to detect, but when paired with a dose of the capsules in the evening did seem to result in sounder, more restorative sleep. 

Overall I felt good about the ingredients and provenance of these products and happy with the results. At $54.99 per bottle of 60 capsules, which would last 30 days if taken per recommendations, the price point is a bit high for me to re-stock my medicine cabinet with this every month. I’d be more likely to pop for an ounce of tincture at $29.99, but with the capsules’ “botanical boost”, I’d say consumers are still getting their money’s worth.

Julie AitchesonJulie AitchesonApril 27, 2020


Canna River, a CBD company based in Thousand Oaks, California, is making a reputation for its focus on high-quality CBD products at the lowest possible price. Using lab-tested CBD made solely from hemp grown in the USA, Canna River offers tinctures, body lotion, balms, and pre-rolls, with more products currently in development. 

The CBD tincture I sampled was a 2.02 ounce bottle containing 5000 milligrams of CBD (85 milligrams per dose). The ingredients include organic MCT oil, full-spectrum hemp extract, and natural terpenes. “Flavor” (which the website further defines as “food-grade flavor extract”) and sucralose complete the ingredient list, but I am not clear on what value these add to the product, as it tastes much the same as other MCT-based oils I have tried that lack those additives. 

This is the highest potency CBD product I have sampled to date, and I was pleasantly surprised by the fast-acting effects and the reasonable price point at $100 per bottle. I am a historically bad sleeper and have tried everything from Tylenol PM to shamanic drumming tracks to self-medicate. I even participated in a sleep study at the University of Virginia that involved cognitive behavioral therapy and wearing a tracking device on my wrist. It worked for a while until I forgot all of the behaviors I learned and backslid into insomnia once again. 

I am fairly sensitive to herbs of all varieties and CBD in particular, so I made sure not to take Canna River’s 5000mg formula until I was safely tucked into bed with my overdue library book. I dosed myself with 85mg (or one dropperful), which I allowed to sit under my tongue for thirty seconds before swallowing as directed. Within twenty-five minutes, I found myself fighting to keep my eyes open before remembering that allowing them to close was the whole point. The next thing I knew, it was morning. I felt rested, and the chronic neck stiffness that I’ve been experiencing as the result of an overly enthusiastic foray into online Pilates classes was noticeably absent. 

I’ve continued to use Canna River at the same dose, with similar results. It does not hit me like a ton of bricks, despite the high potency, nor do I experience any sluggishness in the morning upon waking. I intend to continue enjoying Canna River CBD tincture down to the very last drop, as well as a better night’s rest than I’ve experienced since the Obama administration. 

Julie AitchesonJulie AitchesonApril 20, 2020


Company: Her Royal Hempress

Product: Absolute Glow Face Serum

Founder: Emma Spivey

Emma Spivey’s fondest childhood memories consist of the family matriarchs passing on their horticultural wisdom. Yearning to her roots, Spivey returned to Texas after close to a decade as an agency copywriter in NYC to learn plant medicine and herbalism firsthand. A new mom to an active toddler, Emma creates products that she trusts for her family, combining her passion for CBD and the botanicals she’s learned over the decades.


As a woman in her mid-forties who passed large chunks of her life near the equator (and equal portions sprawled on rooftops, marinated in tanning oil), I take my skincare regimen very seriously. My skin is combination tending towards dry, but I am not one of those dermatological divas who thinks nothing of slathering layers of toxic pharmaceuticals on her face to sip a few lingering drops from the fountain of youth. I like my skincare products clean, cost-effective, and multi-purpose when possible, but those who expound the virtues of facial serum (a lightweight moisturizer often applied under a heavier moisturizer, sunscreen, or make-up primer) are legion, so I was game to give Absolute Glow Face Serum a try.

Her Royal Hempress specializes in cannabidiol-infused skincare products made with small-batch blends of CBD and botanical ingredients. Their products are all paraben, sulfate, formaldehyde, artificial color, and petroleum-free, and Her Royal Hempress sources from only four hemp farms to ensure purity and potency. The company’s founder is momtrepreneur and herbalist Emma Spivey, who comes from a long line of gardeners and possesses a new mothers’ commitment to creating products that won’t compromise the health of her family or her consumers. A portion of the company’s proceeds goes towards preserving and creating wildflower habitat for butterflies and bees, which rounds out Her Royal Hempress’ profile as a boutique company with lofty, eco-conscious goals.

As for the serum, I found the texture a bit heavy and waxy upon initial application, but was pleased with the eventual absorption and added hydration before applying my go-to daily moisturizer. I did not care for the scent, which faintly recalled Play-Doh, but did see some improved clarity to my skin tone by the time I finished the 1 oz. bottle. This may be due to Vitamin C or hyaluronic acid listed as two of the products’ key ingredients. At $60 per ounce, Absolute Glow Face Serum reflects the cost and quality of its raw ingredients, but I may need to try another bottle before committing to a longer-term investment in this latest addition to the flourishing field of CBD skincare.



Julie AitchesonJulie AitchesonApril 10, 2020


Product Review: Peak Extracts

Thanks to the unexpected exigencies of my new 100% work-from-home lifestyle and the daily stressors of living through a pandemic, the tension in my neck and shoulders have achieved code red status. Hours hunched over a keyboard, cringing while listening to the news, and dragging myself through yet another online workout have all taken their toll.

Fortunately for me, Peak Extracts’ line of pain-relieving Rescue Rubs (which include two 125 mg formulas- one CBD and the other CBDa with 100% Hawaiian hemp, as well as a 175 mg formula) have a silky consistency that absorbs well without a greasy finish. Each rub emits a citrusy, herbaceous scent that perfectly masks hemp’s trademark musty odor. The ingredients list is all-natural, without any confusing additives, and the company’s manufacturing process shows a commitment to sustainable practices. But does this stuff work?

With oils such as lavender, lemongrass, cinnamon, and bergamot in Peak Extract’s trademark 12-herb blend, their line of Rescue Rubs provide an aromatherapeutic experience in addition to an analgesic one. I’ve been applying these rubs individually throughout the day up to an hour or so before bed and the achy, frozen feeling in my neck and shoulders has significantly reduced.

The 175 mg formula seems to take effect the fastest and last the longest, but I have experienced some degree of relief with all of them. I have even taken to keeping the jars of Rescue Rub by my computer, on my bathroom counter, and on my nightstand to help me remember to use them consistently. Peak Extracts’ Rescue Rubs absorb the fastest and smell the best of any I’ve tried thus far, and as long as I remember to reapply every four hours or so, I am virtually pain-free. I couldn’t have happened upon them at a better time.

The Peak Extract Story

Kate and Katie started Peak in 2014, but by then Katie had already been a medical patient for nearly ten years, and had been making Single-Strain Chocolates to control symptoms of her Crohn’s disease for most of that time. She discovered that specific strains of cannabis were of great help but others didn’t do much good or had unwanted side effects. Her goal was to be able to control both the dosage and the effects of cannabis administration, in a time where both were commonly left to chance. When we started the company in 2014, the goal was to provide the same custom-tailored edibles experience to Oregon medical market. They transitioned to the adult use market in 2016 and were one of the first edibles processors licensed in Oregon. Katie’s college friend Veronica joined the team in 2016 as well, bringing her legal and regulatory experience to the company.

Our CEO and Founder, Katie, is also a Chinese herbalist.  She maintains an acupuncture and herbal medicine practice in Portland that she’s had since 2010. She created the formula for Rescue Rub based on a topical herbal combination for blunt force trauma and inflammation that was written more than 2,000 years ago.  She used it in her practice to treat arthritis and muscle pain, then when Peak was formed she modified the formula by adding cannabis oil.  We have reports of it helping with everything from neuropathy to muscle strains to healing tattoos.  The other herbs in the formula synergize with the THC, a known analgesic, and create a stronger topical that is absorbed faster into the tissues.  It takes about 5 minutes to take effect and lasts about 4 hours.  We’ve found it to be invaluable for people who need pain relief but are worried about psychoactive effects.

Julie AitchesonJulie AitchesonMarch 5, 2020


On a recent trip to my local market, picking through early spring produce and studiously avoiding my most overworked winter staples, I came across a new contender for my next vegetable serving– baby hemp leaves. Layered in a clear plastic clamshell, the distinctive emerald leaves were curated by a lengthy, laminated discourse affixed to the produce cooler on the culinary benefits of the hemp plant.

The baby hemp leaves, which came from South Mountain MicroFARM in Boonsboro, MD (and which I purchased for $6, took home, steamed, and served with a dash of apple cider vinegar and spoonful of kimchi), were advertised as having zero THC content and below 1% CBD. What the leaves did contain, according to the write-up, was a veritable smorgasbord of nutrients including folate, iron, calcium, and Vitamin C. This was preceded by language regarding the benefits of consuming greens in general for digestion, immunity, and alleviating arthritic conditions. 

I contacted South Mountain MicroFARM for comment on their baby hemp enterprise but did not receive a response. This is likely due to the spring farmer’s scramble rather than any desire to avoid scrutiny. Hemp containing no THC and less than 1% CBD lands well within Maryland State guidelines approving the sale and transport of industrial hemp not exceeding .3% THC, a law that has recently been modified to stipulate that plants be tested no more than 15 days after harvest.

Though the advent of baby hemp to the market in my home state of West Virginia was news to me, the first farmer to take hemp to the grocery aisle did so in New York state back in 2017. An article for Bloomberg News by Kate Krader profiled J.D. Farms in Eaton, NY, which specializes in organic food products and was the first agricultural operation to sell fresh hemp for culinary use.

Though co-founders Mark Justh and Dan Dolgin originally planted hemp as a cover crop, they soon found that the untapped market for culinary hemp held great potential. They marketed their hemp greens as the “new kale”, along with more tried and true hemp seed oil and hemp seeds, whose attributes have long been extolled by nutritionists and Whole Foodists alike.

Appealing adjectives like “lemony”, “minty”, and “sweet” have been used to describe the taste of hemp leaves, so I had high hopes for my culinary adventure. After receiving a recommendation from the clerk at the market (she prefers them sautéed in eggs with feta), I elected to steam the hemp in order to experience it in a relatively unadulterated form.

What resulted was something similar in texture to steamed nettles (which can be a little gritty and fuzzy-textured) and tasting, to me, like the hoppiest IPA imaginable. I could not detect anything “sweet” or “lemony” in the greens, and wished (after my addition of apple cider vinegar and kimchi failed to mask the taste) that I had taken the store clerk’s advice. Even if “baby hemp” is the new kale, I’m sticking with kale.


Julie AitchesonJulie AitchesonMarch 2, 2020


Hemp industry darling, Charlotte’s Web (OTC:CWBHF), which bills its product line as “the world’s most trusted hemp extract” and was ranked as the top brand by market share for CBD by Nasdaq in 2019, is one of the most recent examples of a large-scale CBD producer to be targeted by a class-action lawsuit.  Litigation ranging in focus from CBD content to marketing (e.g. treatment claims) and stock pricing are on the rise as the Federal Drug Administration issues increasingly tighter restrictions on what is permissible in the world of hemp products. 

In the case of Charlotte’s Web, a class-action lawsuit was filed in the state of California alleging that the company has been marketing its products as “dietary supplements”. This is a designation strictly prohibited by the FDA due to the fact that CBD is an ingredient in an FDA-investigated and approved drug (the anti-epileptic, Epidiolex). The FDA claims that this occurred before any CBD products were marketed as dietary supplements which, under the dietary supplement act, are regulated as food. This timeline distinction is crucial, as companies may have been able to avoid this scrutiny if the dietary supplement designation in their marketing had occurred before CBD came under investigation as a drug by the FDA. Charlotte’s Web and Infinite Products, another big name in CBD also based in Colorado, are both standing by their products and marketing and are determined to fight the litigious wave currently on the rise.

Big companies make big targets, but there are still thousands of products and retail outlets across the country slipping through regulatory loopholes. Which is not to say that they are necessarily angling for this state of affairs to continue. The longer FDA guidelines remain inconclusive and enforcement inconsistent, the more vulnerable companies (particularly smaller operations) become the kind of litigation that could drive them out of business permanently. A recent article on went so far as to say that producers are begging for regulations in order to better protect themselves from these risks.

Though the first lawsuits against CBD product companies date back to the earliest days of the CBD boom, these mostly pertained to an inconsistency between the advertised versus actual potency of products or baldly inflated claims about the products curative capacity, particularly in regards to chronic or life-threatening illnesses. With more definitive censure from the FDA of CBD brands that market themselves as dietary supplements, the field is wide open for litigators to go after any product that has CBD as an ingredient, even if the company is not making unsubstantiated claims or falsifying CBD content. 

This being the case, the hemp industry can expect to see more lawsuits crop up in the weeks and months to come. In the meantime, the FDA continues to play a game of catch up to try to get a handle on hemp and how to ensure consumer safety before even more serious consequences of a still-arbitrarily regulated industry come calling.

Julie AitchesonJulie AitchesonFebruary 26, 2020


Those within the U.S. cannabis industry concerned that President Trump’s trade war with China would present significant difficulties to their sector are finding distraction, if not relief, from an unlikely source– the now-global coronavirus outbreak. As a major supplier of cut-rate hemp fiber and CBD for the world market, China has proven stiff competition for United States’ suppliers both domestically and internationally. The disruption of that supply chain by the coronavirus outbreak means that U.S. producers could finally gain an advantage in domestic and international markets.

This does not mean that there won’t still be a significant downside to slowed or stalled production in China due to the necessity of managing this new, virulent strain of coronavirus identified as COVID-19.  The majority of parts that go into manufacturing vaporizer devices, greenhouse components, LED lighting, and products with Chinese-made steel and aluminum packaging are all sourced in China. Delays in accessing these components could cause serious issues for businesses who rely on their ready availability to meet the demands of consumers in a competitive market. The impact will primarily be felt in the hardware manufacturing sector, as a number of factories supplying vaporizer components are in viral “hot zones” in China, and have been shut down until the virus is brought under control. 

About 90 percent of vaporizing products are manufactured in Shenzen, China, where manufacturers were hit hard by a sharp drop in demand brought on by the vape health scare that began dominating headlines in fall of 2019. This created a glut of vaping hardware, though this glut has been all but exhausted by rising demand due the shutdown of multiple Shenzen factories. How long these facilities will stay offline is unknown, as China remains the epicenter of the disease that the World Health Organization maintains has not yet reached pandemic status.

Some CBD product manufacturers in the U.S. have been quick to pivot their marketing campaigns to promote cannabidiol’s potential as a preventative for coronavirus due to its ability to promote restful sleep (important for immune function) and as a treatment for coronavirus symptoms. While this practice is not yet widespread, it will undoubtedly draw considerable ire and negative attention from the FDA, which has already gotten more serious about cracking down on unsubstantiated health claims in the CBD industry. 

While there may yet be a plausible medicinal use for cannabidiol in the unfolding drama of COVID-19, the industry remains focused on coronavirus’s impact on the market for cannabis and cannabis-derived products. Financial markets across the globe (which as of February 26, 2020 were experiencing a definitive downward turn) have been far from immune from the rising hysteria that a pandemic is inevitable. What this means for the hemp industry, and so many others who trace the origins of their manufacturing pipelines back to China, is a question whose answer may yet be many months down the road.

Julie AitchesonJulie AitchesonFebruary 20, 2020


Amidst concerns on the federal and state levels about violations of FDA regulations regarding CBD products, efforts are being made to allocate more money in the upcoming fiscal year to further define and more stringently enforce CBD laws. President Trump’s proposed budget for fiscal year 2021, should he gain re-election and have the opportunity to present it to Congress, allocates an additional $5 million to the Food and Drug Administration specifically for further regulation and law enforcement pertaining to cannabis and cannabis-derived products. This is the first time that CBD has been mentioned in a federal budget proposal, which suggests that hemp and CBD may be buzzwords cropping up in Presidential debate topics alongside marijuana  leading up to the election.

So where would it leave the future of CBD regulation if Trump is ousted from the White House? Democratic Presidential frontrunners Bernie Sanders and Elizabeth Warren both support legalization of cannabis, with Sanders proposing to legalize within 100 days of his election to office. A historically outspoken proponent of the war on drugs, Joe Biden is sticking to a half-measure platform with a focus on decriminalization, allowing states to regulate hemp for themselves. Michael Bloomberg supports putting legalization in the hands of individual states, though he is personally opposed to legalization. Pete Buttigieg takes the side of veterans with PTSD who often use cannabis and its derivatives to deal with the aftermath of military service, advocating for the decriminalization of all controlled substances. 

As  hemp has yet to be a talking point for presidential candidates, overshadowed as it is by the larger topic of marijuana as a flashpoint for racial justice issues (as criminalization disproportionately affects people of color), what Americans can expect from future budgetary support should a Democrat win office is unclear. What is clear is that the time for comprehensive, consistent regulations and enforcement of cannabis laws on the part of the FDA is long overdue.

 During his January 2020 testimony before the Subcommittee on Health, Committee on Energy and Commerce, and the U.S. House of Representatives, Douglas C. Throckmorton, Deputy Director for Regulatory Programs at the FDA, highlighted the current illegality (per the Food, Drug, & Cosmetic Act)  of interstate commerce of food with CBD additives. He also described in some detail concerns with current CBD marketing tactics that put consumers at risk, such as those products that claim to treat cancer or Alzheimer’s. Throckmorton also identified some particular concerns related to the potential negative health impacts of CBD use, such as liver damage, problematic drug interactions, male reproductive toxicity, and various ill side effects. 

While studies of these impacts are still ongoing and inconclusive, the FDA is clearly intent on taking them, and the future of CBD in the U.S. market, seriously. Whether the President-elect of the United States, whoever he or she may be, manages to pass a budget that supports the FDA in its mission to ensure public safety in regards to CBD is, in many respects, for voters to decide.

Julie AitchesonJulie AitchesonFebruary 19, 2020


Even though the FDA has expressed its displeasure at adding CBD to food, that hasn’t stopped hamburger chains from tossing in some cannabidiol to enhance their burgers. The trend was started last year when on April 20th   of 2019 (yep, that’s 4/20), Carl’s Jr. became the first fast-food chain to sell a CBD burger at one of its franchises in Denver, Colorado. The ambitiously named “Rocky Mountain High: Cheeseburger Delight” was composed of two beef patties, pickled jalapenos, pepper jack cheese, fries, and a Santa Fe sauce infused with 5mg of CBD. And the price? $4.20, of course.

The “Rocky Mountain High”, which was only available for one day, was more of a concept test than a menu change, and given that the location sold more than 100 of them within the first hour and ran out entirely by 4 pm, it was one that the CBD burger passed with flying colors. 

That has sparked Colorado-based Illegal Burger to offer what it calls its biggest differentiator, “its exclusive line of CBD products.” The chain is using the idea of CBD burgers as a way to entice new franchisees. On its website, it states, “As an Illegal Burger franchise owner, you will: Be part of the first CBD restaurant franchise in the U.S.” The company backs its decision by saying, “Cannabinoid, or CBD, is attributed to many health benefits. Recently, the FDA approved of its use to treat two forms of childhood epilepsy, and consumers report it positively impacting anxiety, sleep disorders, and even chronic pain.”

The CBD burger was good for business and, according to reporting by Mike Adams at, even healthier for consumers than a dose of CBD all by itself. Adams cites a study that dosed two separate groups of participants with CBD. One group was placed under fasting conditions (no breakfast), while the other group was fed a high-fat meal. Those who partook of the high-fat meal before consuming a dose of CBD appeared to have a higher absorption rate (as demonstrated by a higher concentration of CBD in their systems) than their fasting counterparts.

So will Carl’s Jr. and Illegal Burgers along with the absorption rate study lead more fast food restaurant chains to jump on the CBD bandwagon in the months and years to come? To a large extent, this depends on how far the FDA goes in doubling down on restrictions prohibiting the addition of CBD to foods and dietary supplements in interstate commerce. Food safety officials in Maine, New York City, Ohio, North Carolina, South Carolina, Florida, and Georgia have all banned the addition of CBD to food.

An April 2019, an  Inverse article on the Carl’s Jr. CBD burger reveals that the Federal Food, Drug, and Cosmetic Act prohibiting any active substance in a pharmaceutical (which, thanks to the advent of  FDA-approved anti-seizure medication Epidiolex, CBD is) from being added to food products further empowers regulators to crack down on the issue. Yet despite the fact that these laws are clearly worded with little room for interpretation, their enforcement still appears to be discretionary, as both the FDA and hemp companies scramble to definitively ensure that the CBD available to the public is pure, potent, and safe.

While private chefs and smaller-scale restaurants are still tempting fate (and upping their prices) to bring CBD and cannabis to the dining public, higher-profile establishments are taking the precautionary principle until federal regulations and law enforcement sort themselves out. Still, given that a National Restaurant Association survey identified CBD and cannabis-infused foods as the top restaurant trend in 2019, there’s still a chance that American consumers might be seeing some “special sauce” on offer at their local drive-thru. 

About Us

The Hemp Market Report will target news from the fast growing worlds of cannabidiol (CBD) and hemp. As a sister site to the Green Market Report, HMR will cover financial stories, but also take a look at lifestyle news as well. The Hemp Market Report will also publish sponsored content as we seek to expand our content offerings.


Recent Tweets

@GreenMarketRpt – 5 days

⁦@SharkTankBlogr⁩ Original Kevin Harrington Talks About Joining ⁦@CannapreneurP⁩ ⁦@HarringtonKevin⁩ ⁦…

@GreenMarketRpt – 1 week

RT : “Zelira Therapeutics Ltd () could be changing the way we approach autism.” via Read more here:…

Back to Top

You have Successfully Subscribed!